Benign Essential Blepharospasm Clinical Trials

• Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
  ClinicalTrials.gov Identifier: NCT00234507 - Completed
  Blepharospasm
  
• Brain Stimulation to Treat Blepharospasm or Meige Syndrome
  ClinicalTrials.gov Identifier: NCT00411255 - Recruiting
  Blepharospasm; Focal Dystonia
  
• NT 201 Versus Placebo in the Treatment of Blepharospasm
  ClinicalTrials.gov Identifier: NCT00406367 - Recruiting
  Blepharospasm
  
• Brain Changes in Blepharospasm
  ClinicalTrials.gov Identifier: NCT00500799 - Recruiting
  Blepharospasm
  
• Blepharospasm Short Interval
  ClinicalTrials.gov Identifier: NCT00507637 - Not yet recruiting
  Blepharospasm
  
• rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter.
  ClinicalTrials.gov Identifier: NCT00145366 - Active, not recruiting
  Benign nontoxic and toxic goiter; Graves'' disease
  
• A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00127179 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Benign Prostatic Hyperplasia Trial With Avodart And Tamsulosin Combination Treatment
  ClinicalTrials.gov Identifier: NCT00090103 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00384930 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
  ClinicalTrials.gov Identifier: NCT00316732 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
  ClinicalTrials.gov Identifier: NCT00328965 - Active, not recruiting
  Essential Hypertension
  
• rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter.
  ClinicalTrials.gov Identifier: NCT00275171 - Recruiting
  Benign Nontoxic Nodular Goitre
  
• Laser Therapy of Benign Thyroid Nodules
  ClinicalTrials.gov Identifier: NCT00150150 - Active, not recruiting
  Benign solitary solid; cystic thyroid nodules
  
• A Safety/Efficacy Trial of Zonisamide for Essential Tremor
  ClinicalTrials.gov Identifier: NCT00223743 - Active, not recruiting
  Essential Tremor
  
• Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00366119 - Active, not recruiting
  Essential Hypertension
  
• Kinetics of the Finasteride Prostate Induced Apoptosis
  ClinicalTrials.gov Identifier: NCT00130767 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00343551 - Active, not recruiting
  Essential Hypertension
  
• Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
  ClinicalTrials.gov Identifier: NCT00368979 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Efficacy of Rostafuroxin in the Treatment of Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00415038 - Active, not recruiting
  Essential Hypertension
  
• Safety and Efficacy of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00437645 - Active, not recruiting
  Essential Hypertension
  
• Vardenafil In Benign Prostate Hypertrophy
  ClinicalTrials.gov Identifier: NCT00461123 - Recruiting
  Benign Prostate Hyperplasia (BPH)
  
• A Study of T2000 in Essential Tremor
  ClinicalTrials.gov Identifier: NCT00321087 - Active, not recruiting
  Essential Tremor
  
• Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00284518 - Recruiting
  Benign Prostatic Hyperplasia
  
• Randomized, Double Blinded, Trial of Pomegranate Tabs vs Placebo-Effects on Symptoms of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00381108 - Recruiting
  Benign Prostatic Hyperplasia
  
• Multi-Carotenoids in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00501371 - Recruiting
  Benign Prostatic Hyperplasia
  
• Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia in Asian Men
  ClinicalTrials.gov Identifier: NCT00540124 - Recruiting
  Benign Prostatic Hyperplasia
  
• Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00386009 - Recruiting
  Benign Prostatic Hyperplasia
  
• Mexiletine for the Treatment of Focal Dystonia
  ClinicalTrials.gov Identifier: NCT00001784 - Completed
  Blepharospasm; Dystonia; Spasm
  
• A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization
  ClinicalTrials.gov Identifier: NCT00465101 - Recruiting
  Benign Prostatic Hyperplasia
  
• A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor
  ClinicalTrials.gov Identifier: NCT00524056 - Recruiting
  Essential Tremor, Movement Disorders
  
• Cetrorelix Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
  ClinicalTrials.gov Identifier: NCT00449150 - Recruiting
  Benign Prostatic Hypertrophy
  
• The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00345124 - Recruiting
  Essential Hypertension
  
• Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00380289 - Recruiting
  Essential Hypertension
  
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00438945 - Recruiting
  Essential Hypertension
  
• Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00425373 - Recruiting
  Essential Hypertension
  
• Brain Changes in Blepharospasm
  ClinicalTrials.gov Identifier: NCT00487383 - Recruiting
  Dystonia; Focal Dystonia; Cerebellar Disease
  
• The Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial
  ClinicalTrials.gov Identifier: NCT00135551 - Active, not recruiting
  Essential Hypertension; Cardiovascular Disease
  
• A Pilot Clinical Trial Of Memantine for Essential Tremor
  ClinicalTrials.gov Identifier: NCT00439699 - Recruiting
  Essential Tremor
  
• L-Arginine Metabolism in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00137124 - Recruiting
  Essential Hypertension
  
• Olmesartan in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00185172 - Active, not recruiting
  Essential Hypertension
  
• PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
  ClinicalTrials.gov Identifier: NCT00407953 - Recruiting
  Benign Prostatic Hyperplasia (BPH)
  
• Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00449618 - Recruiting
  High-Normal Blood Pressure; Mild Essential Hypertension
  
• Effectiveness of Eplerenone to Improve Target Organ Damage in Patients with Resistant Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00138944 - Recruiting
  Essential Hypertension
  
• Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
  ClinicalTrials.gov Identifier: NCT00047190 - Active, not recruiting
  chronic idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia
  
• Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
  ClinicalTrials.gov Identifier: NCT00527605 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• Comparing Synthetic Bone Alone Versus Synthetic Bone with Bone Marrow in Bone Lesions
  ClinicalTrials.gov Identifier: NCT00147823 - Recruiting
  Benign bone lesion
  
• Photoselective Vaporization of the Prostate Compared to Transurethral Resection of the Prostate for the Treatment of Benign Hyperplasia of the Prostate
  ClinicalTrials.gov Identifier: NCT00527371 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)
  ClinicalTrials.gov Identifier: NCT00199550 - Active, not recruiting
  BPH; Benign Prostatatic Hyperplasia
  
• A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.
  ClinicalTrials.gov Identifier: NCT00379067 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Diuretics In the Management of Essential Hypertension (DIME) Study
  ClinicalTrials.gov Identifier: NCT00131846 - Recruiting
  Thiazide diuretics; Essential Hypertension; Type 2 Diabetes; Randomized clinical trial; Cost-effectiveness
  
• Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
  ClinicalTrials.gov Identifier: NCT00347061 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00430508 - Not yet recruiting
  Essential Hypertension
  
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00430950 - Not yet recruiting
  Essential Hypertension
  
• A-Protein Levels in Adult and Pediatric Brain Tumor Patients
  ClinicalTrials.gov Identifier: NCT00165542 - Active, not recruiting
  Malignant or Benign Lesions of the Central Nervous System
  
• Imatinib Mesylate in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00039416 - Active, not recruiting
  Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia; Chronic Myelomonocytic Leukemia
  
• The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
  ClinicalTrials.gov Identifier: NCT00427219 - Active, not recruiting
  Benign Prostatic Hypertrophy
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00006367 - Active, not recruiting
  idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Agnogenic Myeloid Metaplasia
  
• Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
  ClinicalTrials.gov Identifier: NCT00274417 - Active, not recruiting
  Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
  
• Novel Therapies for Essential Tremor
  ClinicalTrials.gov Identifier: NCT00018564 - Completed
  Essential Tremor
  
• Laser Prostatectomy Database and Registry
  ClinicalTrials.gov Identifier: NCT00159406 - Recruiting
  BPH; Benign Prostatic Hyperplasia; Enlarged Prostate
  
• Study to Determine the Efficacy of Perindopril to Prevent the Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00461903 - Not yet recruiting
  Essential Hypertension; Atrial Fibrillation
  
• Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
  ClinicalTrials.gov Identifier: NCT00499317 - Recruiting
  Chronic Prostatitis (CP); Chronic Pelvic Pain Syndrome (CPPS); Painful Bladder Syndrome (PBS); Benign Frequency Syndrome (BFS); Benign Daytime Frequency Syndrome (BDFS)
  
• Levetiracetam for Benign Rolandic Epilepsy
  ClinicalTrials.gov Identifier: NCT00181116 - Active, not recruiting
  Epilepsy
  
• Optical Clearing of the Skin in Conjunction With Laser Treatments
  ClinicalTrials.gov Identifier: NCT00580736 - Enrolling by invitation
  Port Wine Stain; Benign Vascular Lesion; Nevus of Ota; Tattoos; Scars; Acne; Hypertrichosis; Sebaceous Hyperplasia
  
• Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00002792 - Active, not recruiting
  Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia
  
• Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00416390 - Active, not recruiting
  Precancerous/Nonmalignant Condition; Prostate Cancer
  
• Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00399464 - Active, not recruiting
  Prostatic Hyperplasia
  
• SAMBA-Thailand: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
  ClinicalTrials.gov Identifier: NCT00401661 - Active, not recruiting
  Prostatic Hyperplasia
  
• Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
  ClinicalTrials.gov Identifier: NCT00400894 - Active, not recruiting
  Prostate Cancer; Benign Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia
  
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00344110 - Active, not recruiting
  Hypertension
  
• SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
  ClinicalTrials.gov Identifier: NCT00486785 - Active, not recruiting
  Prostatic Hyperplasia
  
• Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00407329 - Recruiting
  BPH
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Postoperative Urinary Retention and UTI After LAVH for Benign Disease
  ClinicalTrials.gov Identifier: NCT00564135 - Active, not recruiting
  Hysterectomy; Urinary Retention; Urinary Tract Infection
  
• A Clinical Trial Comparing Laser TURP With and Without Dutasteride.
  ClinicalTrials.gov Identifier: NCT00431626 - Recruiting
  Benign Prostatic Hyperplasia
  
• Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients with Essential Hypertension (Banyu Study)
  ClinicalTrials.gov Identifier: NCT00092209 - Active, not recruiting
  Hypertension
  
• Testosterone Replacement and Dutasteride Effectiveness (TRADE) Study
  ClinicalTrials.gov Identifier: NCT00194675 - Recruiting
  Hypogonadism; Benign Prostatic Hyperplasia
  
• Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
  ClinicalTrials.gov Identifier: NCT00359905 - Recruiting
  Benign Prostatic Hyperplasia
  
• Colonizing Neurogenic Bladders With Benign Flora
  ClinicalTrials.gov Identifier: NCT00371631 - Recruiting
  Urinary Tract Infection; Spinal Cord Injury
  
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
  ClinicalTrials.gov Identifier: NCT00446524 - Active, not recruiting
  Hypertension
  
• Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
  ClinicalTrials.gov Identifier: NCT00342303 - Active, not recruiting
  Fatty Acid Metabolism
  
• Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate)
  ClinicalTrials.gov Identifier: NCT00037141 - Completed
  Prostate Disease; BPH; Benign Prostatic Hyperplasia; Benign Prostatic Hypertrophy
  
• Dose Escalation Study with QLT0074 for Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00077012 - Completed
  Benign Prostatic Hyperplasia
  
• Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00104936 - Active, not recruiting
  grade I meningioma
  
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
  ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
  Essential Hypertension
  
• One-Year Prospective Observational Study of BMI Change Effect of 5-Alpha Reductase Inhibitor in Korean BPH Patients
  ClinicalTrials.gov Identifier: NCT00472251 - Recruiting
  Benign Prostatic Hyperplasia
  
• Nuclear Morphology of Breast Cells in Ductal Lavage
  ClinicalTrials.gov Identifier: NCT00259597 - Recruiting
  Benign Breast Disease
  
• Levothyroxine Treatment in Thyroid Benign Nodular Goiter
  ClinicalTrials.gov Identifier: NCT00552253 - Recruiting
  Thyroid Nodule
  
• A Randomized Study of Sulindac in Oral Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00299195 - Recruiting
  Leukoplakia, Oral; Benign Neoplasms
  
• A Phase II Study of the Pharmacokinetics of Anagrelide in Elderly and Young ET Patients
  ClinicalTrials.gov Identifier: NCT00413634 - Recruiting
  Essential Thrombocythaemia
  
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
  ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
  Essential Hypertension
  
• Physiological Brain Atlas Development
  ClinicalTrials.gov Identifier: NCT00575081 - Recruiting
  Parkinson's Disease; Dystonia; Essential Tremor; OCD
  
• 1-Octanol to Treat Essential Tremor
  ClinicalTrials.gov Identifier: NCT00001986 - Completed
  Essential Tremor
  
• Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00409357 - Completed
  Benign Prostatic Hyperplasia
  
• Determination of Fraction Size Equivalent Dose (FED) Dose Levels for Intracranial Conformal Avoidance Radiotherapy
  ClinicalTrials.gov Identifier: NCT00214175 - Recruiting
  Low Grade Gliomas and Benign CNS Lesions
  
• Octanol to Treat Essential Tremor
  ClinicalTrials.gov Identifier: NCT00080366 - Completed
  Essential Tremor
  
• Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate
  ClinicalTrials.gov Identifier: NCT00169767 - Recruiting
  Benign Prostatic Hyperplasia
  
• The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients
  ClinicalTrials.gov Identifier: NCT00497939 - Recruiting
  Prostatic Hyperplasia; Adrenergic Alpha-Antagonists
  
• Olmesartan and an Add-on Treatment in Patients With Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00311155 - Recruiting
  Essential Hypertension
  
• Pharmacosurveillance and Pharmacogenetics of First-Line Diuretics in Hypertension: The StayOnDiur Study
  ClinicalTrials.gov Identifier: NCT00408512 - Recruiting
  Essential Hypertension